Delcath Systems (DCTH) vs OrthoPediatrics (KIDS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Delcath Systems (DCTH) has outperformed OrthoPediatrics (KIDS) over the past year, gaining 41.2% versus a gain of 20.6%. Over five years, DCTH leads with a +63.2% price change compared with -65.6% for KIDS. OrthoPediatrics is the larger company by market cap ($565.3 million vs $533.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DCTH | KIDS |
|---|---|---|
| Share price | $15.36 | $21.65 |
| Market cap | $532.97M | $565.28M |
| 1-day change | +2.13% | -0.51% |
| YTD return | +52.08% | +21.90% |
| 1-year return | +41.18% | +20.61% |
| 5-year return | +63.23% | -65.60% |
| Forward P/E | 341.33 | — |
| EPS (TTM) | $0.01 | $-1.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.42 | $26.74 |
| 52-week low | $8.12 | $14.42 |
| Distance from 52-week high | -11.83% | -19.04% |
| Analyst consensus | none | none |
| Avg. price target upside | +56.25% | +25.73% |
| Average volume | 479.73K | 211.79K |
| Shares outstanding | 34.70M | 26.11M |
| Employees | 156 | 602 |
| Sector | Health Care | Healthcare |
| Industry | Medical/Dental Instruments | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DCTH has outperformed KIDS by 20.6 percentage points over the past year.
- The two companies sit in different sectors: Delcath Systems in Health Care and OrthoPediatrics in Healthcare.
About Delcath Systems
DCTH stock →Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Health Care · Medical/Dental Instruments · 156 employees
About OrthoPediatrics
KIDS stock →OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products.
Healthcare · Medical Devices · 602 employees
DCTH vs KIDS FAQ
Which is bigger, Delcath Systems or OrthoPediatrics?
OrthoPediatrics (KIDS) is larger, with a market capitalization of $565.28M compared with $532.97M for Delcath Systems (DCTH).
Which stock has performed better over the past year, DCTH or KIDS?
DCTH returned +41.18% over the past 12 months, compared with +20.61% for KIDS (price return, excluding dividends). Past performance does not predict future results.
Are Delcath Systems and OrthoPediatrics in the same industry?
No. Delcath Systems is in the Health Care sector, while OrthoPediatrics is in Healthcare.